Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model

AIM: To improve anti-inflammatory activity while reducing drug doses, we developed a nanoformulation carrying dexamethasone and butyrate. METHODS: Dexamethasone cholesteryl butyrate-solid lipid nanoparticles (DxCb-SLN) were obtained with the warm microemulsion method. The anti-inflammatory activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Dianzani, Chiara, Foglietta, Federica, Ferrara, Benedetta, Rosa, Arianna Carolina, Muntoni, Elisabetta, Gasco, Paolo, Della Pepa, Carlo, Canaparo, Roberto, Serpe, Loredana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483494/
https://www.ncbi.nlm.nih.gov/pubmed/28694660
http://dx.doi.org/10.3748/wjg.v23.i23.4200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483494/
https://www.ncbi.nlm.nih.gov/pubmed/28694660
http://dx.doi.org/10.3748/wjg.v23.i23.4200

Ejemplares similares